♟️ Tuesday 25 August 2026 Tue, 25 Aug 2026

NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.

Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.

Steadfast Group delivered double-digit underlying EBITA growth in FY26 alongside a recommended $6 per share acquisition offer, reflecting a premium of nearly 52%. The insurer broker network continues to expand, supported by technology upgrades and international acquisitions.

Ingenia Communities Group (ASX: INA) reported an 18% rise in FY26 EBIT to $193.4 million, beating guidance, while underlying EPS grew 16% to 35.8 cents. The group also extended its land lease development pipeline to 8,800 sites, underpinning future growth.

CVC Limited posted a net profit after tax of $7.7 million for FY2026, underpinned by a $37.8 million profit from the Laverton sale and a $13.3 million impairment from the Liverpool project. The company paid a special dividend and restructured leadership amid ongoing capital management efforts.

Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.

AIX has acquired an 8% holding in AI powerhouse Databricks during its US$5 billion funding round, marking a significant expansion in the trust’s AI-focused portfolio.

humm Group reports a 60% drop in FY26 net profit after tax to $15.7 million, weighed down by irregular legal expenses and credit impairments, while declaring a final dividend and completing major board renewal.

Abacus Group (ASX:ABG) posted a statutory net loss of $74.5 million for FY26, driven by a $122.1 million accounting hit from reclassifying its Storage King stake following management internalisation, while Funds from Operations dipped slightly and distributions were held steady.

HighCom Limited’s FY26 results reveal a sharp revenue drop and widening loss driven by a US Government shutdown, but a strengthened leadership team and expanded global sales pipeline set the stage for recovery.

Peet Limited delivered a record FY26 with net profit after tax soaring 77% to $103.4 million, driven by robust sales and a 39% jump in contracts on hand. The company boosted dividends by 68%, reflecting confidence in its diverse masterplanned communities pipeline.

Integral Diagnostics (ASX: IDX) delivered a robust FY26 with 26% revenue growth to $788.6 million, a 677% surge in profit after tax to $22 million, and a 50% hike in its final dividend to 6 cents per share.

Viva Energy posted a robust half-year profit of $452 million, powered by soaring refining margins and resilient retail and industrial sales, while managing a significant fire at its Geelong Refinery.

Genetic Signatures narrowed its FY2026 net loss by 30% to $14 million amid a strategic overhaul, signing a key 10-year supply deal with Denmark’s Hvidovre Hospital and resetting its US market approach.

Underwood Capital Limited (ASX:UWC) posted a 21% drop in profit after tax to $0.193 million for FY26, weighed down by a $1.8 million loss on its Weed Me stake despite gains in listed securities. The company’s net tangible assets held steady at $19.3 million, supported by ongoing share buybacks amid persistent share price discounts.

Propel Funeral Partners (ASX:PFP) posted a modest 0.3% revenue rise to $226.6 million in FY26, while operating EBITDA and NPAT slipped slightly. The company completed four acquisitions during the year, maintained dividends, and refinanced debt to extend maturities and improve funding capacity.

Desert Minerals has delivered a maiden JORC Mineral Resource Estimate for its Scotty Lithium Project in Nevada, outlining a substantial lithium clay deposit of 264.9 million tonnes at 1,006 ppm lithium, alongside a sizeable Exploration Target that hints at further growth.

Scentre Group reported a 24.6% jump in half-year profit to $974.5 million despite an 8.3% dip in revenue, driven by strategic sales and robust leasing activity. The group upgraded its full-year FFO and distribution guidance, highlighting a confident outlook.

Jcurve Solutions (ASX:JCS) posted a significant financial turnaround in FY2026, with revenue climbing 16.3% to $13.28 million and normalised EBITDA more than doubling to $1.88 million, underpinned by disciplined cost control and recurring revenue growth.

Carindale Property Trust (ASX: CDP) reported a robust 50.7% jump in net profit for FY26, boosted by a $25.6 million property revaluation gain, alongside an 8.8% rise in funds from operations and a 5% lift in distributions.

XPON Technologies (ASX: XPN) posted a $1.1 million positive EBITDA in FY26 on 38% revenue growth, shedding Alpha Digital and selling its Google Marketing business to focus on its Wondaris AI platform.

Tyro Payments delivered a robust FY26 with profit before tax up 40%, driven by growth in payments and banking, alongside strategic expansion via the Thriday acquisition and new CEO Nigel Lee’s leadership.

Coles Group reported a 2.8% rise in FY26 sales revenue to $45.58 billion, driven by supermarket growth and digital gains, while navigating $235 million in regulatory provisions.